Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammation01:38

Inflammation

46.6K
Overview
46.6K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Inflammatory Response01:28

Inflammatory Response

12.5K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
12.5K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

2.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Acute Inflammation II: Local and Systemic Effects01:25

Acute Inflammation II: Local and Systemic Effects

56
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
56
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding the burden of pulmonary arterial hypertension among patients and caregivers through narrative medicine: data from Italian multicentre observational INSPECTIO study.

BMJ open respiratory research·2026
Same author

Narratives unveil knowledge and awareness-related issue, reinforcing patients' self-identity in sickle cell disease.

Orphanet journal of rare diseases·2026
Same author

Atrial fibrillation increases left and right atrial pressures in patients with chronic heart diseases.

ESC heart failure·2026
Same author

A novel multimodal imaging approach for working diagnosis of acute myocardial infarction with non-obstructive coronary arteries: a promising diagnostic strategy.

Frontiers in cardiovascular medicine·2026
Same author

Exploring the human experience of congenital aniridia: A narrative medicine approach.

European journal of ophthalmology·2025
Same author

Comparison of the Right Atrial Expansion Index with Inferior Vena Cava Assessment for Echocardiographic Estimation of the Right Atrial Pressure.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography·2025

Related Experiment Video

Updated: May 4, 2026

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

6.0K

Targeting inflammation: impact on atherothrombosis.

Maria Giulia Marini1, Chiara Sonnino, Marco Previtero

  • 1Institute of Cardiology, Catholic University, Largo Vito, Rome, 00168, Italy.

Journal of Cardiovascular Translational Research
|December 12, 2013
PubMed
Summary

Inflammation significantly contributes to atherothrombosis, a major global health issue. Anti-inflammatory drugs show promise in preventing and treating this condition, with ongoing research into specific cytokine antagonists.

More Related Videos

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.0K
On-Chip Endothelial Inflammatory Phenotyping
12:43

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

10.4K

Related Experiment Videos

Last Updated: May 4, 2026

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

6.0K
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.0K
On-Chip Endothelial Inflammatory Phenotyping
12:43

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

10.4K

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Pharmacology

Background:

  • Atherothrombosis represents a significant global health burden, causing widespread death and disability.
  • The complex pathophysiology of atherothrombosis involves inflammatory processes from initiation to complication.
  • Recent decades have seen increasing evidence highlighting the critical role of inflammation.

Purpose of the Study:

  • To review the role of inflammatory processes in atherothrombosis.
  • To explore the potential of anti-inflammatory agents in managing atherothrombosis.
  • To summarize current evidence and ongoing research on anti-inflammatory treatments.

Main Methods:

  • Literature review of studies on atherothrombosis and inflammation.
  • Analysis of evidence for anti-inflammatory drugs (e.g., statins, renin-angiotensin inhibitors).
  • Discussion of ongoing clinical trials targeting specific cytokines.

Main Results:

  • Inflammatory processes are integral to the development and progression of atherothrombosis.
  • Some existing medications, such as statins and renin-angiotensin inhibitors, demonstrate anti-inflammatory effects beneficial in atherothrombosis.
  • Current data on anti-inflammatory treatments are not yet conclusive.

Conclusions:

  • Inflammation is a key factor in atherothrombosis, necessitating anti-inflammatory therapeutic strategies.
  • Further research, including trials on cytokine antagonists, is crucial to establish definitive anti-inflammatory treatments for atherothrombosis.
  • Targeting inflammation holds significant potential for managing this widespread disease.